Skip to Main content

Keywords

Researcher identifiers

Social networks

Number of documents

47

Yves Collette


CRCM (INSERM, AMU, Institut Paoli calmettes, CNRS)


Journal articles45 documents

  • Aude de Gassart, Kieu-Suong Le, Patrick Brune, Sophie Agaugué, Jennifer Sims, et al.. Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response. Science Translational Medicine, American Association for the Advancement of Science (AAAS), 2021, 13 (616), ⟨10.1126/scitranslmed.abj0835⟩. ⟨inserm-03540734⟩
  • Abdullah Aldehaiman, Afaque Momin, Audrey Restouin, Luyao Wang, Xiaoli Shi, et al.. Synergy and allostery in ligand binding by HIV-1 Nef. Biochemical Journal, Portland Press, 2021, 478 (8), pp.1525 - 1545. ⟨10.1042/bcj20201002⟩. ⟨hal-03380308⟩
  • Florent Colin, Kristine Schauer, Ali Hamiche, Pierre Martineau, Jean-Paul Borg, et al.. The NANOTUMOR consortium - Towards the Tumor Cell Atlas. Biology of the Cell, Wiley, 2021, 113 (6), pp.272-280. ⟨10.1111/boc.202000135⟩. ⟨hal-03169719⟩
  • Lucille Stuani, Marie Sabatier, Estelle Saland, Guillaume Cognet, Nathalie Poupin, et al.. Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia. Journal of Experimental Medicine, Rockefeller University Press, 2021, 218 (5), pp.e20200924. ⟨10.1084/jem.20200924⟩. ⟨hal-03563454⟩
  • Andria Rakotomalala, Quentin Bailleul, Clara Savary, Mélanie Arcicasa, Maud Hamadou, et al.. H3.3K27M Mutation Controls Cell Growth and Resistance to Therapies in Pediatric Glioma Cell Lines. Cancers, MDPI, 2021, 13 (21), pp.5551. ⟨10.3390/cancers13215551⟩. ⟨hal-03418323⟩
  • A. Collignon, M. Hospital, C. Montersino, F. Courtier, A. Charbonnier, et al.. A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study. Blood Cancer Journal, Nature Publishing Group, 2020, 10 (6), pp.64. ⟨10.1038/s41408-020-0330-5⟩. ⟨inserm-03038330⟩
  • Florent Amatore, Nicolas Ortonne, Marc Lopez, Florence Orlanducci, Rémy Castellano, et al.. ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells. Blood Advances, The American Society of Hematology, 2020, 4 (20), pp.5203-5214. ⟨10.1182/bloodadvances.2020002395⟩. ⟨hal-03152734⟩
  • Florent Amatore, Nicolas Ortonne, Marc Lopez, Florence Orlanducci, Rémy Castellano, et al.. ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells. Blood Advances, The American Society of Hematology, 2020, 4 (20), pp.5203-5214. ⟨10.1182/bloodadvances.2020002395⟩. ⟨hal-03623228⟩
  • Florent Amatore, Nicolas Ortonne, Marc Lopez, Florence Orlanducci, Rémy Castellano, et al.. ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells. Blood Advances, The American Society of Hematology, 2020, 4 (20), pp.5203-5214. ⟨10.1182/bloodadvances.2020002395⟩. ⟨inserm-03038313⟩
  • Jeremy Ariey‐bonnet, Kendall Carrasco, Marion Le Grand, Laurent Hoffer, Stéphane Betzi, et al.. In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor. Molecular Oncology, Elsevier, 2020, 14, pp.3083 - 3099. ⟨10.1002/1878-0261.12810⟩. ⟨hal-02989358⟩
  • Chantal Lagresle-Peyrou, Aurélien Olichon, Hanem Sadek, Philippe Roche, Claudine Tardy, et al.. A gain-of-function RAC2 mutation is associated with bone-marrow hypoplasia and an autosomal dominant form of severe combined immunodeficiency. Haematologica, Ferrata Storti Foundation, In press, ⟨10.3324/haematol.2019.230250⟩. ⟨hal-02545998⟩
  • Abir Arfaoui, Claire Rioualen, Violette Azzoni, Guillaume Pinna, Pascal Finetti, et al.. A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells. EMBO Molecular Medicine, Wiley Open Access, 2019, 11 (10), pp.e9930. ⟨10.15252/emmm.201809930⟩. ⟨hal-02539524⟩
  • Amélie Fouqué, Olivier Delalande, Mickael Jean, Rémy Castellano, Emmanuelle Josselin, et al.. Correction to A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells. Journal of Medicinal Chemistry, American Chemical Society, 2019, 62 (20), pp.9339-9340. ⟨10.1021/acs.jmedchem.9b01578⟩. ⟨hal-02526957⟩
  • Norbert Vey, Marie Anne Hospital, Aude Collignon, Yves Collette, Daniel Birnbaum, et al.. Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients. Blood, American Society of Hematology, 2018, 132 (1), ⟨10.1182/blood-2018-99-119263⟩. ⟨hal-02143630⟩
  • Laurent Hoffer, Yuliia Voitovich, Brigitt Raux, Kendall Carrasco, Christophe Muller, et al.. Integrated Strategy for Lead Optimization Based on Fragment Growing: The Diversity-Oriented-Target-Focused-Synthesis Approach. Journal of Medicinal Chemistry, American Chemical Society, 2018, 61 (13), pp.5719-5732. ⟨10.1021/acs.jmedchem.8b00653⟩. ⟨hal-02067797⟩
  • Aude Le Roy, Thomas Prebet, Remy Castellano, Armelle Goubard, Florence Riccardi, et al.. Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities. Frontiers in Immunology, Frontiers, 2018, 9, pp.977. ⟨10.3389/fimmu.2018.00977⟩. ⟨hal-01791593⟩
  • M. M-Rabet, O. Cabaud, E. Josselin, P. Finetti, R. Castellano, et al.. Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer. Annals of Oncology, Elsevier, 2017, ⟨10.1093/annonc/mdw678⟩. ⟨hal-01787533⟩
  • Maria de Grandis, Florence Bardin, Cyril Fauriat, Christophe Zemmour, Abdessamad El-Kaoutari, et al.. JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia. Cancer Research, American Association for Cancer Research, 2017, 77 (23), pp.6627-6640. ⟨10.1158/0008-5472.CAN-17-1223⟩. ⟨hal-01789603⟩
  • Thomas Farge, Estelle Saland, Fabienne de Toni, Nesrine Aroua, Mohsen Hosseini, et al.. Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism. Cancer Discovery, American Association for Cancer Research, 2017, 7 (7), pp.716-735. ⟨10.1158/2159-8290.cd-16-0441⟩. ⟨inserm-02465205⟩
  • Brigitt Raux, Yuliia Voitovich, Carine Derviaux, Adrien Lugari, Etienne Rebuffet, et al.. Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins. Journal of Medicinal Chemistry, American Chemical Society, 2016, 59 (4, SI), pp.1634-1641. ⟨10.1021/acs.jmedchem.5b01708⟩. ⟨hal-01439086⟩
  • Sabine Milhas, Brigitt Raux, Stéphane Betzi, Carine Derviaux, Philippe Roche, et al.. Protein-Protein Interaction Inhibition (2P21)-Oriented Chemical Library Accelerates Hit Discovery. ACS Chemical Biology, American Chemical Society, 2016, 11 (8), pp.2140-2148. ⟨10.1021/acschembio.6b00286⟩. ⟨hal-01439116⟩
  • Audrey Benyamine, A. Le Roy, Emilie Mamessier, J. Gertner-Dardenne, C. Castanier, et al.. BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia.. OncoImmunology, Taylor & Francis, 2016, ⟨10.1080/2162402X.2016.1146843⟩. ⟨inserm-01416288⟩
  • Tania M. Puvirajesinghe, François Bertucci, Ashish Jain, Pierluigi Scerbo, Edwige Belotti, et al.. Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2–JNK signalling in breast cancer. Nature Communications, Nature Publishing Group, 2016, 7, pp.10318. ⟨10.1038/ncomms10318⟩. ⟨hal-01447570⟩
  • S. Milhas, S. Betzi, P. Roche, M. Cholay, A. Restouin, et al.. Accelerating small compounds discovery targeting protein-protein interaction. FEBS Journal, Wiley, 2015, 282 (1, SI), pp.134. ⟨hal-01439038⟩
  • Y Collette, Thomas Prébet, A. Goubard, José Adelaïde, R Castellano, et al.. Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia. Blood Cancer Journal, Nature Publishing Group, 2015, 5 (e292), ⟨10.1038/bcj.2015.13⟩. ⟨hal-01218497⟩
  • E Saland, H Boutzen, R Castellano, L Pouyet, E Griessinger, et al.. A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia. Blood Cancer Journal, Nature Publishing Group, 2015, 5 (e297), ⟨10.1038/bcj.2015.19⟩. ⟨hal-01219119⟩
  • Amelie Fouque, Olivier Delalande, Mickael Jean, Remy Castellano, Emmanuelle Josselin, et al.. A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells. Journal of Medicinal Chemistry, American Chemical Society, 2015, 58 (16), pp.6559-6573. ⟨10.1021/acs.jmedchem.5b00991⟩. ⟨hal-01187307⟩
  • Guilhem Chaubet, Thibault Coursindel, Xavier Morelli, Stéphane Betzi, Philippe Roche, et al.. Stereoselective synthesis of original spirolactams displaying promising folded structures.. Organic and Biomolecular Chemistry, Royal Society of Chemistry, 2013, 11 (28), pp.4719-26. ⟨10.1039/c3ob40643a⟩. ⟨hal-00871067⟩
  • Marion A. Salvador, Julien Wicinski, Olivier Cabaud, Yves Toiron, Pascal Finetti, et al.. The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression. Clinical Cancer Research, American Association for Cancer Research, 2013, 19 (23), pp.6520-6531. ⟨10.1158/1078-0432.CCR-13-0877⟩. ⟨hal-01431936⟩
  • Marine Malleter, Sebastien Tauzin, Alban Bessede, Remy Castellano, Armelle Goubard, et al.. CD95L cell surface cleavage triggers a pro-metastatic signaling pathway in triple negative breast cancer.. Cancer Research, American Association for Cancer Research, 2013, 73 (22), pp.6711-21. ⟨10.1158/0008-5472.CAN-13-1794⟩. ⟨hal-00873634⟩
  • Xiaoli Shi, Stéphane Betzi, Adrien Lugari, Sandrine Opi, Audrey Restouin, et al.. Structural recognition mechanisms between human Src homology domain 3 (SH3) and ALG-2-interacting protein X (Alix). FEBS Letters, Wiley, 2012, 586, pp.1759-1764. ⟨10.1016/j.febslet.2012.05.017⟩. ⟨hal-00717171⟩
  • J. Gertner-Dardenne, R. Castellano, Emilie Mamessier, S. Garbit, E. Kochbati, et al.. Human V 9V 2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts. Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2012, 188 (9), pp.4701 - 4708. ⟨10.4049/jimmunol.1103710⟩. ⟨hal-01765650⟩
  • Xiaoli Shi, Sandrine Opi, Adrien Lugari, Audrey Restouin, Thibault Coursindel, et al.. Identification and biophysical assessment of the molecular recognition mechanisms between the human hemopoietic cell kinase Src homology domain 3 and ALG-2-interacting protein X. Biochemical Journal, Portland Press, 2010, 431 (1), pp.93-102. ⟨10.1042/BJ20100314⟩. ⟨hal-00517249⟩
  • Thilbault Coursindel, Audrey Restouin, Georges Dewynter, Jean Martinez, Yves Collette, et al.. Stereoselective ring contraction of 2,5-diketopiperazines : An innovative approach to the synthesis of promising bioactive 5-membered scaffolds. Bioorganic Chemistry, Elsevier, 2010, 38, pp.210-217. ⟨10.1016/j.bioorg.2010.05.002⟩. ⟨hal-00599350⟩
  • Xiaoli Shi, Sandrine Opi, Adrien Lugari, Audrey Restouin, Thibault Coursindel, et al.. Identification and biophysical assessment of the molecular recognition mechanisms between the human haemopoietic cell kinase Src homology domain and ALG-2-interacting protein X. Biochemical Journal, Portland Press, 2010, 431, pp.93-102. ⟨10.1042/BJ20100314⟩. ⟨hal-00600207⟩
  • Sophie Reuse, Miriam Calao, Kabamba Kabeya, Allan Guiguen, Jean-Stéphane Gatot, et al.. Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.. PLoS ONE, Public Library of Science, 2009, 4 (6), pp.e6093. ⟨10.1371/journal.pone.0006093⟩. ⟨hal-00464770⟩
  • K. Ohara, M. Smietana, A. Restouin, S. Mollard, J.-P. Borg, et al.. Amine guanidine switch : a promising approach to improve DNA binding and antiproliferative activities.. Journal of Medicinal Chemistry, American Chemical Society, 2007, 50, pp.6465-6475. ⟨10.1021/jm701207m⟩. ⟨hal-00346603⟩
  • Stéphane Betzi, Audrey Restouin, Sandrine Opi, Stefan T Arold, Isabelle Parrot, et al.. Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein.. Proceedings of the National Academy of Sciences of the United States of America , National Academy of Sciences, 2007, 104 (49), pp.19256-61. ⟨10.1073/pnas.0707130104⟩. ⟨hal-00473817⟩
  • Hervé Chambost, Yves Collette, Hélène Dutartre, Isabelle Thuret, Daniel Olive. Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study. Leukemia Research, Elsevier, 2000, 24 (10), pp.823-830. ⟨10.1016/s0145-2126(00)00053-9⟩. ⟨hal-02459277⟩
  • A Greenway, H Dutartre, K Allen, D Mcphee, D Olive, et al.. Simian immunodeficiency virus and human immunodeficiency virus type 1 nef proteins show distinct patterns and mechanisms of Src kinase activation.. Journal of Virology, American Society for Microbiology, 1999, 73 (7), pp.6152-8. ⟨hal-02459367⟩
  • G Zauli, D Gibellini, P Secchiero, H Dutartre, D Olive, et al.. Human immunodeficiency virus type 1 Nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway.. Blood, American Society of Hematology, 1999, 93 (3), pp.1000-10. ⟨hal-02459371⟩
  • Jean-Marie Peloponese, Yves Collette, Catherine Grégoire, Christian Bailly, Daniel Campèse, et al.. Full Peptide Synthesis, Purification, and Characterization of Six Tat Variants. Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 1999, 274 (17), pp.11473-11478. ⟨10.1074/jbc.274.17.11473⟩. ⟨hal-02137983⟩
  • Hélène Dutartre, Mark Harris, Daniel Olive, Yves Collette. The Human Immunodeficiency Virus Type 1 NEF Protein Binds the Src-Related Tyrosine Kinase Lck SH2 Domain Through a Novel Phosphotyrosine Independent Mechanism. Virology, Elsevier, 1998, 247 (2), pp.200-211. ⟨10.1006/viro.1998.9244⟩. ⟨hal-02459372⟩
  • Y. Collette, H. Dutartre, A. Benziane, D. Olive. The role of HIV1 Nef in T-cell activation: Nef impairs induction of Th1 cytokines and interacts with the Src family tyrosine kinase Lck. Research in virology, Elsevier, 1997, 148 (1), pp.52-58. ⟨10.1016/s0923-2516(97)81914-0⟩. ⟨hal-02459374⟩
  • Y. Collette, H. Dutartre, A. Benziane, D. Olive, V. Collette. Similarity between Nef of primate lentiviruses and p15E of murine and feline leukaemia viruses. AIDS, Lippincott, Williams & Wilkins, 1996, 10 (4), pp.441. ⟨10.1097/00002030-199604000-00013⟩. ⟨hal-02459381⟩

Book sections1 document

  • Y. Collette, Nikolaus Hansen, Gilles Pujol, Daniel Salazar Aponte, Rodolphe Le Riche. On Object-Oriented Programming of Optimizers - Examples in Scilab. Rajan Filomeno Coelho and Piotr Breitkopf. Multidisciplinary Design Optimization in Computational Mechanics, Wiley, pp. 499-538, 2010. ⟨inria-00476172⟩

Preprints, Working Papers, ...1 document

  • Lucille Stuani, Marie Sabatier, Feng Wang, Nathalie Poupin, Claudie Bosc, et al.. Combinatory therapy targeting mitochondrial oxidative phosphorylation improves efficacy of IDH mutant inhibitors in acute myeloid leukemia. 2020. ⟨hal-02935177⟩